Fusion Antibodies are today announcing a revision to its service offering for production of Monoclonal Antibodies.
With these changes we hope to allow greater flexibility and options to a wider variety of clients and reduce the barriers of entry for the academic and SME market. Fusion Antibodies antibody production services had previously included (as standard) adaptation of the final clones into a supplement free media but in order to reduce the cost and bring our service closer in line with that of our competitors we have now made this an optional stage. This move will allow individuals or companies who would like to first test the new antibodies in their assays before they are adapted to their final scale-up ready the option to do so with world-class provider Fusion Antibodies.
More details about the monoclonal antibody production service are available on the service page, or contact Fusion Antibodies today on +44 (0)28 9043 2800 or email email@example.com